Results 61 to 70 of about 58,767 (165)

Plasminogen Activator Inhibitor 1 [PDF]

, 2020
openaire   +1 more source

Type 1 plasminogen activator inhibitor

Japanese Journal of Thrombosis and Hemostasis, 1990
openaire   +3 more sources

A contemporary review of plasminogen activator inhibitor 1 in cardiovascular disease and broader disease state implications. [PDF]

Blood Vessel Thromb Hemost
Becerra M, Soogoor N, Vu J, Wortley J, Sathyamoorthy M.   +4 more
europepmc   +1 more source

Thermodynamics and selection of the plasminogen activator inhibitor-1 latency transition. [PDF]

J Biol Chem
Haynes LM, Holding ML, Woodard J, Siemieniak D, Ginsburg D.   +4 more
europepmc   +1 more source

Fibroblast circSamd4 promotes cardiac fibrosis via activating plasminogen activator inhibitor-1. [PDF]

Redox Biol
Chen Y, Zhang Z, Cheng Y, Chen X, Zhou J, Wei Z, Yao H, Zhang S, Kong Q, Tang H, Wu W, Zhou Z, Tang X, Liu X.   +13 more
europepmc   +1 more source

Plasma Plasminogen Activator Inhibitor-1 as a Biomarker for Disease Activity and Pharmaco-Response Prediction in Pediatric Epilepsy: A Prospective Cohort Study. [PDF]

Neuropsychiatr Dis Treat
Xiao X, Shi XY, Feng J, Zhou XY, Wang ML, Zhang BB, Xu C, Tang JH.   +7 more
europepmc   +1 more source

Plasminogen activator inhibitor 1 promotes aortic aging-like pathophysiology in humans and mice. [PDF]

J Clin Invest
Khoddam A, Kalousdian A, Eren M, Soberanes S, Decker A, Lux EJ, Zywicki BW, Dinh B, Boztepe B, Cheema BS, Cuda CM, Abdala-Valencia H, Sivakumar A, Miyata T, Wilsbacher LD, Vaughan DE.   +15 more
europepmc   +1 more source

Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus. [PDF]

Rev Assoc Med Bras (1992), 2023
Ozgen L, Ozgen G, Dincgez B, Bayram F.
europepmc   +1 more source

4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status. [PDF]

Thromb J
Zhang X, Guo X.
europepmc   +1 more source

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition. [PDF]

Biomolecules
Fujimura T, Muto Y, Asano Y.
europepmc   +1 more source